These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35026131)

  • 1. Microbial Cgr2 will let your Th17 cells ROR(γT).
    Rodriguez-Marino N; Cervantes-Barragan L
    Cell Host Microbe; 2022 Jan; 30(1):10-12. PubMed ID: 35026131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human gut bacterial metabolism drives Th17 activation and colitis.
    Alexander M; Ang QY; Nayak RR; Bustion AE; Sandy M; Zhang B; Upadhyay V; Pollard KS; Lynch SV; Turnbaugh PJ
    Cell Host Microbe; 2022 Jan; 30(1):17-30.e9. PubMed ID: 34822777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.
    Withers DR; Hepworth MR; Wang X; Mackley EC; Halford EE; Dutton EE; Marriott CL; Brucklacher-Waldert V; Veldhoen M; Kelsen J; Baldassano RN; Sonnenberg GF
    Nat Med; 2016 Mar; 22(3):319-23. PubMed ID: 26878233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2.
    Singh AK; Khare P; Obaid A; Conlon KP; Basrur V; DePinho RA; Venuprasad K
    Nat Commun; 2018 Oct; 9(1):4515. PubMed ID: 30375383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.
    Gao W; Wu Y; Tian Y; Ni B
    Int Rev Immunol; 2015; 34(4):295-304. PubMed ID: 25340306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
    Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
    Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.
    Martin M; Kesselring RK; Saidou B; Brunner SM; Schiechl G; Mouris VF; Wege AK; Rümmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S
    Eur J Immunol; 2015 Jun; 45(6):1667-79. PubMed ID: 25820779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination.
    Kathania M; Khare P; Zeng M; Cantarel B; Zhang H; Ueno H; Venuprasad K
    Nat Immunol; 2016 Aug; 17(8):997-1004. PubMed ID: 27322655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.
    Huang XL; Zhang X; Fei XY; Chen ZG; Hao YP; Zhang S; Zhang MM; Yu YQ; Yu CG
    World J Gastroenterol; 2016 Jun; 22(22):5201-10. PubMed ID: 27298563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation.
    Sun M; He C; Chen L; Yang W; Wu W; Chen F; Cao AT; Yao S; Dann SM; Dhar TGM; Salter-Cid L; Zhao Q; Liu Z; Cong Y
    J Immunol; 2019 Jan; 202(1):79-92. PubMed ID: 30478092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt.
    He Z; Wang F; Zhang J; Sen S; Pang Q; Luo S; Gwack Y; Sun Z
    J Immunol; 2017 Aug; 199(3):955-964. PubMed ID: 28667162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.
    Mudter J; Yu J; Zufferey C; Brüstle A; Wirtz S; Weigmann B; Hoffman A; Schenk M; Galle PR; Lehr HA; Mueller C; Lohoff M; Neurath MF
    Inflamm Bowel Dis; 2011 Jun; 17(6):1343-58. PubMed ID: 21305677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid-Related Orphan Receptor RORγt in CD4
    Mickael ME; Bhaumik S; Basu R
    Am J Pathol; 2020 Oct; 190(10):1984-1999. PubMed ID: 32735890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells.
    Han L; Yang J; Wang X; Wu Q; Yin S; Li Z; Zhang J; Xing Y; Chen Z; Tsun A; Li D; Piccioni M; Zhang Y; Guo Q; Jiang L; Bao L; Lv L; Li B
    J Biol Chem; 2014 Sep; 289(37):25546-55. PubMed ID: 25070893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
    Tada Y; Ono N; Suematsu R; Tashiro S; Sadanaga Y; Tokuda Y; Ono Y; Nakao Y; Maruyama A; Ohta A; Koarada S
    BMC Musculoskelet Disord; 2016 Jul; 17():290. PubMed ID: 27421886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 1,25(OH)2D3 Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene Expression in the PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss (URPL).
    Abdollahi E; Saghafi N; Rezaee SA; Rastin M; Jarahi L; Clifton V; Rafatpanah H
    Iran Biomed J; 2020 Sep; 24(5):295-305. PubMed ID: 32429643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic landscape provides molecular insights into the modes of action of diverse ROR-γt modulators.
    Suri C; Awasthi A; Asthana S
    Drug Discov Today; 2022 Feb; 27(2):652-663. PubMed ID: 34838728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
    Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
    Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.